ArticleInfection2025

Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections- results from a retrospective multicentre study.

Andrea Marino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.